CWM
CHRS icon

CIBC World Markets’s Coherus Oncology CHRS Stock Holding History

CIBC World Markets’s Portfolio CHRS Stock Details CHRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		$9.56K Sell
13,068
-11,871
-48% -$10.2K ﹤0.01% 1548
2025
Q1 		$20.1K Buy
24,939
+14,527
+140% +$16.7K ﹤0.01% 1794
2024
Q4 		$14.4K Buy
+10,412
New +$11.7K ﹤0.01% 1312

Other funds holding CHRS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CWG
C WorldWide Group Copenhagen, Denmark $4.66B AUM 11.67% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return

CIBC World Markets's CHRS Position: Q2 2025 in Review

CIBC World Markets reduced its Coherus Oncology (CHRS) stake by 48% in Q2 2025, selling an estimated $10.2K and leaving 13,068 shares worth $9.56K. The position accounts for ﹤0.01% of the portfolio, ranked #1548.

CIBC World Markets first reported a position in CHRS in Q4 2024 and has held it in 3 quarters since. The position peaked at $20.1K in Q1 2025. 112 funds tracked by Wall St. Rank hold CHRS as of Q2 2025.

  • CIBC World Markets held 13,068 shares of Coherus Oncology worth $9.56K as of Q2 2025.
  • CIBC World Markets sold 11,871 Coherus Oncology shares in Q2 2025, an estimated $10.2K.
  • Coherus Oncology made up ﹤0.01% of CIBC World Markets's portfolio in Q2 2025, its #1548 holding.
  • CIBC World Markets first reported a position in Coherus Oncology in Q4 2024 and has held it in 3 quarters since.
  • CIBC World Markets's Coherus Oncology position peaked at $20.1K in Q1 2025.
  • 112 funds tracked by Wall St. Rank held Coherus Oncology as of Q2 2025.

Based on CIBC World Markets's 13F filing for Q2 2025, filed 14 Aug 2025.